Spyre Therapeutics Inc. SYRE shares are up on Monday following the announcement of positive results from the Phase 2 SKYLINE ...

Spyre Therapeutics’ monoclonal antibody hit the key goal of a phase 2 study in ulcerative colitis (UC), which the company has touted as proof it can best Takeda’s Entyvio. The mid-stage trial ...

Your doctor has told you you have ulcerative colitis (UC), and now you’re learning about the treatment options and lifestyle tweaks that can support your new diagnosis. Along with this medical ...

Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the 10 Stocks With Eye-Popping Gains. Spyre Therapeutics soared to a new four ...

Biologic therapy within a year of diagnosis could decrease risk for disease progression among patients with ulcerative ...

If you have ulcerative colitis (UC), your first line of treatment will likely be medication. But even with medication, sometimes symptoms continue to flare, tanking your quality of life along the way.

Your physical health can affect your mental well-being. Here's how a UC diagnosis specifically might impact your psyche, and ...

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that affects the large intestine, causing persistent inflammation in the colon and rectum. The condition typically begins in the rectum ...

AI could help predict which patients with ulcerative colitis and low-grade dysplasia will progress to colorectal cancer.In an ...

Medications for ulcerative colitis (UC) can treat and prevent flares, but they can also come with some uncomfortable side effects. For example, immunomodulators like azathioprine (Azasan) decrease UC ...

Sharing your ulcerative colitis (UC) diagnosis with a partner or someone you're dating – especially at the beginning, as you get to know each other – can make you feel vulnerable. Life with UC means ...

Ulcerative colitis (UC) is a chronic, immune-mediated inflammatory bowel disease. Because it affects the gastrointestinal tract, many people with UC may feel hesitant to try new foods or expand their ...